Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy - Concepedia

Concepedia

Publication | Open Access

Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy

DOI Full Paper Access

56

Citations

27

References

2018

Year

Nagako Sougawa, Shigeru Miyagawa, Satsuki Fukushima, Ai Kawamura, Junya Yokoyama, Emiko Ito, Akima Harada, Kaori Okimoto, Noriko Mochizuki‐Oda, Atsuhiro Saito,

Scientific Reports

References

	Year	Citations

Page 1